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What do you think are the big questions to be answered next in your field? I would say that there are two types of questions: (1) those we don't yet have answers to, but we probably have the tools and ideas to get there, it's just a matter of time, and (2) those that we really don't know how to tackle yet-we're missing the theoretical understanding that allows tractable approaches to the question.
Examples of the first (feasible/just need time) type of questions include:
(1) what the neural circuit maps underlying basic emotion processing, e.g., fear/threat/avoidance and appetitive/approach behaviors, are; (2) functional dissection of cell types and microcircuits within the critical brain areas (amygdala, hippocampus, accumbens, mPFC, etc.); and (3) if we can pharmacologically target specific circuits by having a more in-depth molecular/ cellular understanding of these circuits. Together, the continued work by the field will likely bring about much more clarity into the mechanisms of basic emotional responses that underlie many psychiatric disorders.
The second type of question remains as much in philosophy as in tractable science: (1) how are psychiatric symptoms clustered at a biological level-though we are hopeful that this will soon move into the first type; (2) how does the brain create consciousness; (3) what are the intermediate phenotypes for awareness; and (4) how does the epiphenomena of population-level, brain-wide circuit activation lead to the experience of the organism as a single being, combined sensory input, and organized integrated behavior, etc.?
Which aspect of science, your field or in general, would you wish the general public knew more about? Psychiatric symptoms are a function of the brain, and most are treatable. We should be no more ashamed or stigmatized by depression, addiction, PTSD, or psychosis than we are by infection, asthma, diabetes, or heart disease. Enormous progress is being made in our understanding of the brain mechanisms of psychiatric disorders, and tractable, rationally designed brain-based neurotherapeutics are on the horizon, but more work is needed.
Science is a living process of discovery and approximating truth rather than representing a definable set of facts. It requires testing, skepticism, revision, and iteration. When viewed as certainty or fact, however, almost certainly one is on the wrong track.
Do you have a favorite anecdote from doing science that you'd like to share (perhaps a key discovery moment)? It was early in my time in Linda Buck's lab. We had rapidly cloned the mouse odorant receptor gene family using a strategy similar to one that Buck and Axel had employed recently to identify the rat receptor genes. The finding of hundreds to thousands of different receptor genes completely changed how the field thought about olfactory information coding, and we had no idea how they would be expressed within the olfactory epithelium-would cells express one or multiple receptor molecules? Would they be expressed in patterns or randomly? Could understanding their expression patterns help us to understand how odors are encoded? In situ hybridization had only been available for a couple of years, but a neighboring lab had it working well. I was able to get several different receptor genes labeled as riboprobes and was developing the slides very late one night; I was the only one in the lab. Despite poor histology, it was immediately clear to me in looking at the olfactory epithelium sections that only a small number of neurons expressed any given receptor gene, likely suggesting cellular specificity, and that the genes appeared to be expressed in patterns in the nose. It took of course many more months of experiments to quantify and replicate these observations, but it was the closest I've come to a ''eureka'' moment of clarity of understanding while also realizing that for a brief moment I was the only person to understand a new biological concept-a quiet, late night, but an unforgettable moment.
Who were your key early influences?
There have been many influences throughout my training. As an undergraduate at MIT, Chip Quinn and Herman Stellar's work in Drosophila neurobiology got me most excited initially about studying molecular mechanisms of neural systems. Also at MIT, I worked in Dick Wurtman's lab with Dr. Ian Acworth, learning intracerebral dialysis and neurotransmitter systems mediating appetitive processing. As a graduate student, I was Linda Buck's first graduate student, and she was an invaluable influence on my scientific career and enthusiasm for science. Many wonderful mentors were at Harvard Neurobiology at the time, including David Hubel, Steve Hyman, Gerry Fischbach, Ed Kravitz, Marge Livingston, David Potter, and Connie Cepko, among others. As a resident and fellow at Emory, Charlie Nemeroff was my initial inspiration into neurobiological approaches to psychiatric disease. Michael Davis was an amazing fellowship mentor; he was very generous and kind and set me off on a career focusing on amygdala approaches to fear-related disorders. Finally, at Emory, Barbara Rothbaum introduced me to the world of exposure/extinctionbased psychotherapies for PTSD and other fear and anxiety disorders, and we remain close collaborators.
What's your favorite experiment?
The set of experiments that I remain most amazed and excited by were initiated by my brilliant postdoc, Brian Dias, PhD, while I was still at Emory (Dias and Ressler, 2014, Nat. Neurosci.) . Brian was quite interested in the possible identification of behavioral processes that might be intergenerationally/epigenetically transmitted. We went back and forth on whether to do these studies for a while, as I was skeptical of how to approach this in a tractable manner. We compromised on a model using the olfactory system, which I was trained in from the Buck lab and for which there were a number of powerful tools available. Furthermore, we had always maintained an olfactory fear conditioning set of experiments in our neurobiology of fear lab. Several years previously (Jones et al., 2008, J. Neurosci.) , Seth Jones in my lab had shown that if a mouse was trained to be afraid of an odor (after a few odor-shock pairings), after 1-2 weeks we would see a marked (30%) increase in number of neurons in the nose and size of the odor-sensitive glomerulus using a transgenic reporter mouse labeled for this specific odorant receptor, effectively showing within the olfactory system similar increases in receptive field representation and sensitivity as had been shown in auditory and visual systems with sensory training.
Remarkably, when Brian mated males trained on this odorant, the offspring and their offspring (the grandchildren) maintained this increased receptive field representation with increased neuronal number and increased glomerular axonal input. This occurred despite the fact that the next generations were entirely naive to odorant exposure. Brian did a large number of control and molecular experiments, including in vitro fertilization, and our current understanding of this process is that the sperm from the initially trained fathers becomes epigenetically marked, with decreased DNA methylation in the odorant receptor gene associated with the odor-fear learning. We hypothesize that these methylation marks escape epigenetic reprograming during development, leading to increased expression of these odorant receptor genes in the next generations. This would allow the next generations to have an ''inherited'' increased sensitivity to odorants that are critically important for survival in their environment.
Obviously many more mechanistic and control experiments are needed to further understand this process, but we are hopeful that this fascinating model and approach will lead to a tractable system for understanding some aspects of intergenerational epigenetic inheritance of certain kinds of environmental information.
What motivated you to become a scientist? Joy of discovery-opportunity to do what I find most exciting and fascinating while being paid for it! What is your view on big data-gathering collaborations as opposed to hypothesis-driven research by small groups? They're both critical, and we also have to figure out what the roles to be played by each are. Team science is critical but also, by definition, coarse in its scope. In contrast, we'll likely never understand mechanism, which generally requires convergent, complementary hypothesisdriven approaches, with team science. Thus, I think of team science, large consortia-driven discovery approaches, as important for discovery of genes and pathways and prioritization of which of the thousands of molecular possibilities are most likely associated with phenotypes and disease. In contrast, small labs and individual approaches will always be needed for understanding mechanisms and molecular relationships between these prioritized pathways.
What advice do you find yourself giving to your students and postdocs? As hard as it can sometimes be, doing Academic Science still remains the most fulfilling and exciting career choice I can imagine. In the US, it is in most places set up where the PI effectively is running a small business (sometimes mediumsized business), with revenue, expenses, management, and personnel processes. Once you accept that, you realize that most 5-year grants offer more security, freedom, and independence than most jobs anywhere in this day and age. So we must remember that no job is easy, and none come with infinite security, but at the end of the day the funding of science is mostly a meritocracy, and if you love doing it, it is an amazing opportunity.
How do you find inspiration?
Talking to others, hearing talks out of my ''comfort zone,'' talking with clinicians, spending time at the intersection of different fields of inquiry, and the science-clinical interface.
What career paths did you consider other than a scientist? Initially computer science or engineering, then medicine. I still love them both and at some level still integrate engineering principles, though I am sadly behind as the computer/technology revolution has exploded. Although I'm a clinical psychiatrist, I practice minimally now, focusing these energies on translating basic and clinical research to trying to identify new understanding and interventions for these disorders.
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